The aims of this study are: i) to enquire whether informing healthy hemoglobinopathy carriers about their condition is a welcome initiative in The Netherlands; ii) to study whether using information letters and thorough explanation is associated with presence or absence of undesired feelings or emotions. We have approached 100 multi-ethnic carriers previously diagnosed in our lab. All subjects had previously received our information letter through their physician who was supposed to have provided an explanation of the letter if required. We have enquired whether the subjects had experienced negative or positive emotions after receiving our diagnosis and explanation and to which degree, if they were sufficiently informed and satisfied and if...
Abstract Background UK and US policy initiatives have suggested that, in the future, patients and cl...
Objectives. In 2007 neonatal screening (NNS) was expanded to include screening for sickle cell disea...
International audienceOBJECTIVE: To explore hereditary haemochromatosis (HH) patients' perspectives ...
Background: In the Netherlands no formal recommendations exist concerning preconceptional or antenat...
BACKGROUND: In the Netherlands no formal recommendations exist concerning preconceptional or antenat...
Objective. To explore factors that influence intention to participate in hemoglobinopathy (HbP) carr...
Objective. To explore factors that influence intention to participate in hemoglobinopathy (HbP) carr...
Copyright © 2013 Sylvia M. van der Pal et al. This is an open access article distributed under the C...
Hemoglobinopathies are highly prevalent conditions, with a global carrier rate of about 7%, and wher...
Abstract: Healthy carriers of severe Hemoglobinopathies are usually asymptomatic and only efficientl...
Since the 1990s, many countries in Europe and the United States have enacted genetic non-discriminat...
Healthy carriers of severe Hemoglobinopathies are usually asymptomatic and only efficiently detected...
Objective: Genetics increasingly permeate everyday medicine. When patients want to make informed dec...
Progress in the field of molecular genetics has made it possible to identify individuals with an inc...
Introduction: 23andMe provides consumers the opportunity to receive genetic information without invo...
Abstract Background UK and US policy initiatives have suggested that, in the future, patients and cl...
Objectives. In 2007 neonatal screening (NNS) was expanded to include screening for sickle cell disea...
International audienceOBJECTIVE: To explore hereditary haemochromatosis (HH) patients' perspectives ...
Background: In the Netherlands no formal recommendations exist concerning preconceptional or antenat...
BACKGROUND: In the Netherlands no formal recommendations exist concerning preconceptional or antenat...
Objective. To explore factors that influence intention to participate in hemoglobinopathy (HbP) carr...
Objective. To explore factors that influence intention to participate in hemoglobinopathy (HbP) carr...
Copyright © 2013 Sylvia M. van der Pal et al. This is an open access article distributed under the C...
Hemoglobinopathies are highly prevalent conditions, with a global carrier rate of about 7%, and wher...
Abstract: Healthy carriers of severe Hemoglobinopathies are usually asymptomatic and only efficientl...
Since the 1990s, many countries in Europe and the United States have enacted genetic non-discriminat...
Healthy carriers of severe Hemoglobinopathies are usually asymptomatic and only efficiently detected...
Objective: Genetics increasingly permeate everyday medicine. When patients want to make informed dec...
Progress in the field of molecular genetics has made it possible to identify individuals with an inc...
Introduction: 23andMe provides consumers the opportunity to receive genetic information without invo...
Abstract Background UK and US policy initiatives have suggested that, in the future, patients and cl...
Objectives. In 2007 neonatal screening (NNS) was expanded to include screening for sickle cell disea...
International audienceOBJECTIVE: To explore hereditary haemochromatosis (HH) patients' perspectives ...